Tarsus Pharmaceuticals, Inc. logo TARS - Tarsus Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 8
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $103.00 DETAILS
HIGH: $116.00
LOW: $89.00
MEDIAN: $102.50
CONSENSUS: $103.00
UPSIDE: 40.79%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2018 Q2 2018 Q1
Revenue
Revenue 173.9 162.1 151.7 118.7 102.7 78.3 66.4 48.1 40.8 27.6 13.1 1.9 0 2.5 10 0 15.3 0.5 0.3 1.2 22.0 33.4 0 0 0 0 0 0 0 0
Cost of Revenue 12.1 9.4 10.9 24.6 6.2 5.2 4.9 3.2 3.0 1.7 1.2 0.4 0.3 0.3 0.4 0.2 0.5 0.0 (0.0) 0.1 0.7 1.3 0 0 0 0 0 0.0 0 0
Gross Profit 161.8 152.7 140.7 94.1 96.4 73.1 61.5 44.9 37.8 26.0 11.9 1.5 (0.3) 2.2 9.6 (0.2) 14.8 0.5 0.4 1.2 21.3 32.1 0 0 0 0 0 (0.0) 0 0
Operating Expenses
R&D Expenses 31.0 22.4 18.0 16.3 15.6 14.4 16.9 12.1 12.3 12.1 13.3 12.1 12.5 12.4 10.0 10.9 9.6 12.1 8.0 10.2 7.2 16.3 7.6 8.0 1.7 1.5 0.7 0.4 0.2 0.2
SG&A Expenses 150.7 136.4 130.7 108.6 103.0 85.0 69.0 57.9 58.8 51.6 43.0 30.3 20.0 14.8 14.6 11.8 10.4 7.9 6.8 6.7 6.8 5.2 3.9 2.1 1.5 0.6 0.4 0.2 0.1 0.1
Other Expenses 0 0 0 (16.3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.7) (0.7)
Operating Expenses 181.7 158.8 148.7 108.6 118.6 99.4 85.9 70.0 71.1 63.6 56.3 42.4 32.5 27.2 24.7 22.7 20.0 20.0 14.8 16.9 14.0 21.4 11.5 10.1 3.3 2.1 1.1 0.6 (0.3) (0.3)
Operating Income
Operating Income (19.9) (6.1) (8.0) (14.5) (22.2) (26.3) (24.4) (25.2) (33.3) (37.7) (44.5) (40.9) (32.8) (25.0) (15.1) (22.9) (5.2) (19.5) (14.4) (15.7) 7.3 10.7 (11.5) (10.1) (3.3) (2.1) (1.1) (0.6) (0.3) (0.3)
Interest Expense 2.2 2.1 2.2 2.1 2.1 2.1 2.2 2.3 2.1 1.0 1.0 0.9 0.8 0.7 0.7 0.6 0.5 0.3 0 0 0 0 0 – 0 0 0.0 0.0 0 0
Interest Income 3.7 3.7 4.0 4.1 4.2 3.5 3.6 4.1 4.1 3.1 3.0 2.8 2.2 2.3 2.1 1.1 0.3 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0 0 0 0
Profitability
EBITDA (12.7) (6.8) (3.7) (12.2) (17.6) (22.4) (20.4) (20.7) (30.9) (34.5) (40.6) (38.1) (30.4) (22.7) (12.8) (21.8) (5.1) (19.9) (14.8) (16.0) 6.5 10.8 (11.4) (10.1) (3.2) (2.1) (1.1) (0.7) (0.3) (0.3)
EBIT (13.7) (7.2) (4.1) (12.6) (18.1) (22.9) (20.8) (21.0) (31.2) (34.7) (40.9) (38.3) (30.6) (22.8) (12.9) (21.9) (5.2) (19.9) (14.8) (16.0) 6.4 10.7 (11.5) (10.1) (3.3) (2.1) (1.1) (0.7) 0 0
Income Before Tax (15.8) (9.3) (6.3) (12.6) (20.3) (25.1) (23.1) (23.4) (33.3) (35.7) (41.9) (39.1) (31.4) (23.4) (13.6) (22.5) (5.7) (20.2) (14.8) (16.0) 6.4 10.7 (11.5) (10.1) (3.2) (2.0) (1.4) (0.7) (0.3) (0.3)
Income Tax Expense 2.7 (2.4) 2.1 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) 0 0.0 0.1 (0.3) 0.0 0.3 0 0.0 0 0 0 0 0.0 0.0
Net Income (18.6) (7.0) (8.4) (12.6) (20.3) (25.1) (23.1) (23.4) (33.3) (35.7) (41.9) (39.1) (31.4) (23.4) (13.6) (22.5) (5.7) (20.2) (14.9) (15.7) 6.3 10.3 (11.5) (10.1) (3.2) (2.0) (1.4) (0.7) (0.3) (0.3)
Per Share Data
EPS (Basic) -0.43 -0.16 -0.20 -0.30 -0.48 -0.64 -0.60 -0.61 -0.88 -1.01 -1.31 -1.28 -1.17 -0.88 -0.53 -0.84 -0.24 -0.98 -0.72 -0.76 0.31 0.51 -0.56 -0.54 -0.30 -0.18 -0.13 -0.06 -0.08 -0.08
EPS (Diluted) -0.43 -0.16 -0.20 -0.30 -0.48 -0.64 -0.60 -0.61 -0.88 -1.01 -1.31 -1.28 -1.17 -0.88 -0.53 -0.84 -0.24 -0.98 -0.72 -0.76 0.29 0.47 -0.54 -0.54 -0.30 -0.18 -0.13 -0.06 -0.08 -0.08
Shares Outstanding 43.4 43.0 42.8 42.6 42.4 39.3 38.6 38.4 37.8 35.3 31.9 30.6 26.8 26.7 25.7 26.7 24.3 20.7 20.6 20.6 20.6 20.3 20.3 18.8 10.9 10.9 10.9 10.9 4.3 4.3
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2019 Q4
Current Assets
Cash & Cash Equivalents 204.6 102.2 183.6 112.7 96.6 175.8 94.8 176.2 181.1 193.7 224.9 226.7 106.8 66.0 71.7 169.5 245.4 175.0 171.3 183.8 176.7 156.2 168.1 86.3 53.1 58.0
Short-Term Investments 245.1 286.5 233.6 289.1 284.5 232.1 196.6 140.7 142.5 104.8 2.5 20.2 71.5 135.2 145.4 57.1 0 0.3 0.5 0 0 0 0 0 0 0
Net Receivables 98.3 117.2 87.1 74.3 60.2 64.2 48.1 30.3 30.8 31.4 17.7 6.4 0.2 2.9 3.6 4.0 0.6 0.3 0.1 0.1 20.2 32.4 0.0 0.0 0.0 0.0
Inventory 4.4 4.6 4.4 3.8 3.9 2.7 2.6 2.8 2.2 4.0 3.1 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 2.3 1.1 0.0
Total Current Assets 562.0 537.2 522.8 501.7 474.4 480.8 356.7 357.1 362.6 340.7 256.1 259.3 183.5 208.6 225.4 234.1 250.3 178.8 176.0 187.1 200.9 191.5 170.7 89.1 54.7 58.0
Non-Current Assets
Property, Plant & Equipment 30.4 27.7 21.7 16.0 3.4 3.2 2.9 4.2 4.2 3.5 3.3 3.6 3.7 1.7 1.5 1.6 1.8 1.8 1.8 1.7 1.0 1.2 1.2 1.4 1.4 0.3
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 6.9 7.1 7.4 7.6 7.8 8.1 8.3 8.6 3.7 3.8 3.9 4.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 6.7 5.9 3.9 5.6 3 3 3 3 3 0 0.6 0.2 0.3 0.3 0.4 0.2 0.2 0.4 0.7 1.5 0 1.2 0 0 0 0
Other Non-Current Assets 5.2 3.2 6.4 3.7 6.3 5.7 6.1 3.4 3.4 1.3 1.5 1.3 1.5 0.5 0.6 0.6 0.6 0.5 0.5 0.1 1.5 0.1 0.1 1.8 0.1 0.0
Total Non-Current Assets 49.2 43.9 39.4 32.9 20.6 20.0 20.3 19.2 14.3 8.6 9.4 9.1 5.5 2.6 2.5 2.4 2.5 2.7 3.0 3.3 2.5 2.5 1.3 3.1 1.5 0.3
Total Assets 611.1 581.1 562.2 534.6 495.0 500.8 377.0 376.3 376.8 349.3 265.5 268.3 188.9 211.2 227.9 236.5 252.8 181.5 178.9 190.4 203.4 194.0 172.0 92.2 56.2 58.3
Current Liabilities
Account Payables 40.1 24.1 16.4 40.6 28.1 28.4 27.7 26.8 26.7 19.1 17.8 10.4 8.2 7.6 5.5 5.6 4.1 4.0 2.9 2.0 3.3 5.0 2.2 4.7 1.4 0.5
Short-Term Debt 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 133.5 110.3 117.5 62.8 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.1 0.1 0.2 0.3 0.3 0.3 0.1 0
Total Current Liabilities 175.8 143.5 135.7 117.0 90.3 86.3 80.6 65.9 51.6 42.5 36.9 23.2 14.8 13.3 15.4 14.3 11.7 12.6 11.5 10.4 10.5 10.1 5.4 6.1 3.1 0.8
Non-Current Liabilities
Long-Term Debt 72.8 72.6 83.0 72.3 72.1 72.0 71.8 71.7 71.6 29.9 29.8 29.7 24.6 24.5 19.4 19.4 19.3 19.2 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 (10.6) 0 0 0 0 1.2 1.4 1.6 1.7 1.7 1.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 103.2 0.1 63.4
Total Non-Current Liabilities 88.7 88.7 83.0 82.4 72.1 72.0 71.8 72.9 73.0 31.5 31.6 31.4 26.4 24.6 19.5 19.6 19.6 19.7 0.7 0.9 0.5 0.6 0.6 103.9 0.8 63.5
Total Liabilities 264.4 232.2 218.7 199.5 162.4 158.3 152.5 138.8 124.6 74.1 68.5 54.7 41.2 37.8 35.0 33.8 31.3 32.3 12.2 11.3 11.0 10.7 6.0 110.0 3.9 64.3
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (452.1) (433.6) (426.6) (418.3) (405.7) (385.3) (360.2) (337.1) (313.7) (280.4) (244.7) (202.8) (163.6) (132.2) (108.8) (95.2) (72.7) (66.9) (46.7) (31.8) (16.1) (22.5) (32.8) (21.4) (11.2) (6.0)
Accumulated Other Comprehensive Income (0.6) (0.3) 0.4 0.3 0.0 0.1 0.2 0.3 (0.2) (0.1) (0.0) (0.0) (0.0) (0.1) (0.1) (0.0) 0 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 346.7 349.0 343.4 335.1 332.6 342.5 224.5 237.5 252.2 275.2 197.0 213.7 147.7 173.4 192.9 202.6 221.5 149.2 166.7 179.1 192.5 183.2 166.0 (17.8) 52.4 (6.0)
Total Liabilities & Equity 611.1 581.1 562.2 534.6 495.0 500.8 377.0 376.3 376.8 349.3 265.5 268.3 188.9 211.2 227.9 236.5 252.8 181.5 178.9 190.4 203.4 194.0 172.0 92.2 56.2 58.3
Debt Metrics
Total Debt 88.7 88.7 93.6 82.5 72.4 72.4 72.5 72.3 72.2 30.5 30.2 30.1 25.0 25.2 20.2 20.1 20.2 20.4 1.9 2.3 2.1 0.7 0.8 0.8 0.9 0.2
Net Debt (115.9) (13.5) (90.0) (30.2) (24.2) (103.4) (22.4) (103.9) (108.9) (163.2) (194.7) (196.5) (81.7) (40.8) (51.5) (149.4) (225.2) (154.6) (169.4) (181.5) (174.6) (155.5) (167.3) (85.5) (52.3) (57.8)
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2018 Q2 2018 Q1
Operating Activities
Net Income (18.6) (7.0) (8.4) (12.6) (20.3) (25.1) (23.1) (23.4) (33.3) (35.7) (41.9) (39.1) (31.4) (23.4) (13.6) (22.5) (5.7) (20.2) (14.9) (15.7) 6.3 10.4 (11.5) (10.1) (3.2) (2.0) (1.4) (0.7) (0.3) (0.3)
Depreciation & Amortization 1 0.4 0.4 0.4 0.5 0.5 0.4 0.3 0.2 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Stock-Based Compensation 13.3 12.0 14.3 12.2 8.2 6.9 7.4 7.4 7.5 5.5 5.5 5.2 5.2 3.9 3.7 3.6 3.5 2.7 2.2 2.1 2.8 1.4 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0
Change in Working Capital 35.0 (29.5) 13.6 19.3 (16.4) (1.9) (5.7) (1.7) 10.3 (8.6) (2.8) 1.4 3.1 (1.4) 0.1 0.0 (2.7) 1.6 0.0 20.2 10.3 (29.2) 0.9 0.1 0.5 (0.1) 0.2 0.0 0.0 0.0
Other Non-Cash Items 36.0 (0.6) (0.6) (1.1) (1.4) (1.0) (1.2) 8.7 0.9 0.7 (0.5) (0.1) (0.9) (1.2) (1.1) 0.2 0.6 0.6 0.5 0.1 0.0 5.6 0.1 3.2 0.0 0.0 0.4 0.0 0.0 0.0
Operating Cash Flow 66.8 (24.7) 19.3 18.3 (29.4) (20.7) (22.2) (8.7) (14.4) (37.8) (39.3) (32.4) (23.8) (22.0) (10.9) (18.6) (4.3) (15.3) (12.1) 7.1 20.6 (11.8) (10.0) (6.6) (2.6) (2.0) (0.8) (0.6) (0.3) (0.3)
Investing Activities
Capital Expenditure (4.1) (5.8) (6.4) (1.9) (1.0) (0.6) (5.1) (0.3) (1.0) (0.2) 0 (4.4) (0.8) (0.3) (0.1) (0.1) (0.1) (0.2) (0.3) (0.1) (0.0) (0.2) 0 (0.1) (0.3) (0.0) (0.0) (0.0) (0.0) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (2.4) (126.8) (36.5) (102.3) (129.7) (125.6) (90.0) (24.1) (50.0) (104.5) 0 0.0 0 (28.7) (92.4) (57.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 44.3 74.1 92.1 99.5 79 91.2 35.5 24.5 10.5 2.5 17.9 51.7 64.9 40.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 (5) 3 0 0 0 (4) 0 0 5.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0
Investing Cash Flow 37.9 (58.6) 49.3 (4.7) (51.7) (34.9) (59.6) 3.1 (40.5) (102.2) 17.9 47.4 64.1 11.3 (87.2) (57.1) (0.1) (0.2) (0.3) (0.1) (0.0) (0.2) 0.1 (0.1) (0.3) (0.0) (0.0) (0.0) (0.0) (0.0)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 (31.9) (0.0) 71.5 0 0 5 0 5 0 0 (0.1) 19.2 0 0 0 0 0 0 0 0 1.0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) (0.0) 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 3.3 0 0 0 0 0 31.9 0 (31.9) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.1) 0.1 0 0 0 0 0
Financing Cash Flow 3.5 1.2 2.3 2.6 2.0 136.6 2.9 0.6 42.3 108.8 19.8 104.9 0.5 5.0 0.3 (0.1) 74.7 19.1 (0.1) 0.1 0.0 0.0 91.8 39.9 0.1 (0.0) 58.4 0.5 0 0
Cash Position
Net Change in Cash 108.2 (82.0) 70.9 16.1 (79.1) 81.0 (78.8) (4.9) (12.6) (31.2) (1.7) 119.9 40.8 (5.7) (97.8) (75.9) 70.4 3.7 (12.5) 7.1 20.5 (11.9) 81.8 33.2 (2.8) (2.1) 57.6 (0.1) 0.6 0.6
Cash at Beginning 102.2 184.2 115.3 99.2 178.3 97.4 176.2 181.1 193.7 224.9 226.7 106.8 66.0 71.7 169.5 245.4 175.0 171.3 183.8 176.7 156.2 168.1 86.3 53.2 55.9 58.0 0.4 0.4 0.0 0.0
Cash at End 210.4 102.2 186.2 115.3 99.2 178.3 97.4 176.2 181.1 193.7 224.9 226.7 106.8 66.0 71.7 169.5 245.4 175.0 171.3 183.8 176.7 156.2 168.1 86.3 53.2 55.9 58.0 0.4 0.6 0.6
Free Cash Flow 62.7 (30.5) 13.0 16.3 (30.4) (21.2) (27.3) (8.9) (15.4) (38.0) (39.3) (36.7) (24.6) (22.3) (11.0) (18.7) (4.4) (15.4) (12.4) 7.0 20.5 (12.0) (10.0) (6.7) (2.9) (2.0) (0.8) (0.6) (0.3) (0.3)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2018 Q2 2018 Q1
Income Statement
Revenue 173.9 162.1 151.7 118.7 102.7 78.3 66.4 48.1 40.8 27.6 13.1 1.9 0 2.5 10 0 15.3 0.5 0.3 1.2 22.0 33.4 0 0 0 0 0 0 0 0
Gross Profit 161.8 152.7 140.7 94.1 96.4 73.1 61.5 44.9 37.8 26.0 11.9 1.5 (0.3) 2.2 9.6 (0.2) 14.8 0.5 0.4 1.2 21.3 32.1 0 0 0 0 0 (0.0) 0 0
Operating Income (19.9) (6.1) (8.0) (14.5) (22.2) (26.3) (24.4) (25.2) (33.3) (37.7) (44.5) (40.9) (32.8) (25.0) (15.1) (22.9) (5.2) (19.5) (14.4) (15.7) 7.3 10.7 (11.5) (10.1) (3.3) (2.1) (1.1) (0.6) (0.3) (0.3)
Net Income (18.6) (7.0) (8.4) (12.6) (20.3) (25.1) (23.1) (23.4) (33.3) (35.7) (41.9) (39.1) (31.4) (23.4) (13.6) (22.5) (5.7) (20.2) (14.9) (15.7) 6.3 10.3 (11.5) (10.1) (3.2) (2.0) (1.4) (0.7) (0.3) (0.3)
EPS (Diluted) -0.43 -0.16 -0.20 -0.30 -0.48 -0.64 -0.60 -0.61 -0.88 -1.01 -1.31 -1.28 -1.17 -0.88 -0.53 -0.84 -0.24 -0.98 -0.72 -0.76 0.29 0.47 -0.54 -0.54 -0.30 -0.18 -0.13 -0.06 -0.08 -0.08
Balance Sheet
Cash & Equivalents 204.6 102.2 183.6 112.7 96.6 175.8 94.8 176.2 181.1 193.7 224.9 226.7 106.8 66.0 71.7 169.5 245.4 175.0 171.3 183.8 176.7 156.2 168.1 86.3 53.1 58.0
Total Assets 611.1 581.1 562.2 534.6 495.0 500.8 377.0 376.3 376.8 349.3 265.5 268.3 188.9 211.2 227.9 236.5 252.8 181.5 178.9 190.4 203.4 194.0 172.0 92.2 56.2 58.3
Total Debt 88.7 88.7 93.6 82.5 72.4 72.4 72.5 72.3 72.2 30.5 30.2 30.1 25.0 25.2 20.2 20.1 20.2 20.4 1.9 2.3 2.1 0.7 0.8 0.8 0.9 0.2
Stockholders' Equity 346.7 349.0 343.4 335.1 332.6 342.5 224.5 237.5 252.2 275.2 197.0 213.7 147.7 173.4 192.9 202.6 221.5 149.2 166.7 179.1 192.5 183.2 166.0 (17.8) 52.4 (6.0)
Cash Flow
Operating Cash Flow 66.8 (24.7) 19.3 18.3 (29.4) (20.7) (22.2) (8.7) (14.4) (37.8) (39.3) (32.4) (23.8) (22.0) (10.9) (18.6) (4.3) (15.3) (12.1) 7.1 20.6 (11.8) (10.0) (6.6) (2.6) (2.0) (0.8) (0.6) (0.3) (0.3)
Capital Expenditure (4.1) (5.8) (6.4) (1.9) (1.0) (0.6) (5.1) (0.3) (1.0) (0.2) 0 (4.4) (0.8) (0.3) (0.1) (0.1) (0.1) (0.2) (0.3) (0.1) (0.0) (0.2) 0 (0.1) (0.3) (0.0) (0.0) (0.0) (0.0) (0.0)
Free Cash Flow 62.7 (30.5) 13.0 16.3 (30.4) (21.2) (27.3) (8.9) (15.4) (38.0) (39.3) (36.7) (24.6) (22.3) (11.0) (18.7) (4.4) (15.4) (12.4) 7.0 20.5 (12.0) (10.0) (6.7) (2.9) (2.0) (0.8) (0.6) (0.3) (0.3)